@hushmoney,
I agree with your statement "A CEO and the board are tied to the fiduciary interest of shareholders", however this shouldn't always be the case with short term SPs.
In this case, the timing of the release of this announcement has indeed seemed to halt the momentum of the stock however, what it hasn't done is shift the fundamentals of the business. In other words, the timing of the announcement should have no long term effects on the SP. The content itself is expected for those who have been following the story and performed some due diligence on the numbers (as you have mentioned).
As a reminder, Mr Nania's terms for vesting his performance rights are all aligned with the fundamentals and the long term performance of the business:Source: https://www2.asx.com.au/markets/company/CXZ - "Appointment of 2 Non-Executive Directors and CEO/MD"
- Renew the GM contract on equal or better terms,
- Onboard a new OEM client,
- Deliver a healthy financial performance for the financial year and of course,
- Sustain a SP of at least $0.25 which aligns with the "fiduciary interest of shareholders"
I think these are the goals that truly matter, the rest is just noise.
On the speculative notes of Mr Nania selling, we can only speculate for now. However if I had to make a bet, it would be that he wouldn't have. I don't think anyone with that many Performance Rights and a newly signed C-Level contract would risk their reputation to do so.
We'll see over the next few days how the hands have changed.
HBMS
- Forums
- ASX - By Stock
- Ann: Appendix 4D & Half Yearly Financial Statements
CXZ
connexion mobility ltd
Add to My Watchlist
4.00%
!
2.6¢

@hushmoney,I agree with your statement "A CEO and the board are...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.6¢ |
Change
0.001(4.00%) |
Mkt cap ! $21.08M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.5¢ | $3.491K | 139.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3335843 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 361617 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3135843 | 0.025 |
5 | 1571000 | 0.024 |
1 | 21000 | 0.023 |
4 | 6068000 | 0.022 |
3 | 194890 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 361617 | 4 |
0.027 | 319000 | 2 |
0.028 | 1184655 | 3 |
0.029 | 460000 | 3 |
0.030 | 50000 | 1 |
Last trade - 13.13pm 27/06/2025 (20 minute delay) ? |
Featured News
CXZ (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online